Legal & General Group’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
1,908,289
+512,024
+37% +$3.39M ﹤0.01% 1071
2025
Q4
$11M Buy
1,396,265
+38,838
+3% +$306K ﹤0.01% 1117
2025
Q3
$11M Sell
1,357,427
-446,776
-25% -$2.97M ﹤0.01% 1157
2025
Q2
$8.43M Buy
1,804,203
+392,589
+28% +$1.8M ﹤0.01% 1279
2025
Q1
$7.75M Buy
1,411,614
+1,181,147
+513% +$4.77M ﹤0.01% 1282
2024
Q4
$781K Buy
230,467
+19,624
+9% +$63.1K ﹤0.01% 2320
2024
Q3
$601K Buy
210,843
+195,973
+1,318% +$503K ﹤0.01% 2399
2024
Q2
$33.5K Buy
14,870
+323
+2% +$651 ﹤0.01% 2860
2024
Q1
$32.1K Hold
14,547
﹤0.01% 2842
2023
Q4
$34.2K Sell
14,547
-788
-5% -$1.45K ﹤0.01% 2867
2023
Q3
$28.5K Sell
15,335
-1,323
-8% -$3.03K ﹤0.01% 2933
2023
Q2
$43.6K Buy
16,658
+84
+0.5% +$214 ﹤0.01% 2890
2023
Q1
$26.9K Hold
16,574
﹤0.01% 2988
2022
Q4
$22K Hold
16,574
﹤0.01% 3131
2022
Q3
$26K Sell
16,574
-8,959
-35% -$14.8K ﹤0.01% 3141
2022
Q2
$39K Buy
+25,533
New +$53.9K ﹤0.01% 3047
2021
Q2
Sell
-5,109
Closed -$23K 3664
2021
Q1
$23K Sell
5,109
-22,799
-82% -$123K ﹤0.01% 3080
2020
Q4
$138K Buy
27,908
+22,500
+416% +$113K ﹤0.01% 2501
2020
Q3
$32K Sell
5,408
-1,050
-16% -$4.2K ﹤0.01% 2829
2020
Q2
$17K Buy
6,458
+324
+5% +$1.13K ﹤0.01% 3140
2020
Q1
$13K Buy
6,134
+709
+13% +$3.05K ﹤0.01% 3097
2019
Q4
$38K Buy
5,425
+964
+22% +$7.96K ﹤0.01% 2931
2019
Q3
$44K Hold
4,461
﹤0.01% 2791
2019
Q2
$48K Buy
4,461
+974
+28% +$10.2K ﹤0.01% 2794
2019
Q1
$35K Buy
3,487
+2,482
+247% +$31.8K ﹤0.01% 2858
2018
Q4
$17K Hold
1,005
﹤0.01% 3149
2018
Q3
$18K Buy
+1,005
New +$21.8K ﹤0.01% 3238

Other funds holding XERS